IL151039A0 - In ovo protection against infectious bronchitis - Google Patents

In ovo protection against infectious bronchitis

Info

Publication number
IL151039A0
IL151039A0 IL15103901A IL15103901A IL151039A0 IL 151039 A0 IL151039 A0 IL 151039A0 IL 15103901 A IL15103901 A IL 15103901A IL 15103901 A IL15103901 A IL 15103901A IL 151039 A0 IL151039 A0 IL 151039A0
Authority
IL
Israel
Prior art keywords
protection against
infectious bronchitis
against infectious
ovo
ovo protection
Prior art date
Application number
IL15103901A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/775,750 external-priority patent/US20010046500A1/en
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of IL151039A0 publication Critical patent/IL151039A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL15103901A 2000-02-29 2001-02-15 In ovo protection against infectious bronchitis IL151039A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51573200A 2000-02-29 2000-02-29
US09/775,750 US20010046500A1 (en) 2000-02-29 2001-02-02 In ovo protection against infectious bronchitis
PCT/US2001/004792 WO2001064244A2 (en) 2000-02-29 2001-02-15 In ovo protection against infectious bronchitis

Publications (1)

Publication Number Publication Date
IL151039A0 true IL151039A0 (en) 2003-04-10

Family

ID=27058588

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15103901A IL151039A0 (en) 2000-02-29 2001-02-15 In ovo protection against infectious bronchitis

Country Status (20)

Country Link
EP (2) EP1259257B1 (xx)
JP (1) JP2003529565A (xx)
CN (1) CN1406135A (xx)
AR (1) AR027558A1 (xx)
AT (1) ATE463253T1 (xx)
AU (1) AU2001237016A1 (xx)
BR (1) BR0108735A (xx)
CA (1) CA2401145A1 (xx)
CY (1) CY1110544T1 (xx)
DE (1) DE60141743D1 (xx)
DK (1) DK1259257T3 (xx)
ES (1) ES2341841T3 (xx)
IL (1) IL151039A0 (xx)
MX (1) MXPA02008254A (xx)
NO (1) NO20024100L (xx)
NZ (1) NZ520761A (xx)
PL (1) PL365447A1 (xx)
PT (1) PT1259257E (xx)
WO (1) WO2001064244A2 (xx)
YU (1) YU65102A (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR031405A1 (es) 2000-11-21 2003-09-24 Wyeth Corp Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
ATE445412T1 (de) * 2003-03-03 2009-10-15 Intervet Int Bv Ein virus der infektiösen bronchitis mit veränderten spike-gen
WO2007072916A1 (ja) * 2005-12-22 2007-06-28 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 卵内接種用ワクチン
MX2018015506A (es) 2016-06-16 2019-05-22 Boehringer Ingelheim Vetmedica Gmbh Vacuna contra virus de bronquitis infecciosa.
KR20210084596A (ko) 2018-10-31 2021-07-07 베링거잉겔하임베트메디카게엠베하 이종 스파이크 단백질을 갖는 h52 ibv 백신
EA202191145A1 (ru) 2018-10-31 2021-08-23 Бёрингер Ингельхайм Ветмедика Гмбх Вакцина виб 4/91 с гетерологичным шиповидным белком
JP2022531731A (ja) 2019-05-10 2022-07-08 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー コロナウイルススパイクタンパク質の改変されたｓ１サブユニット
MX2021013702A (es) 2019-05-10 2021-12-10 Boehringer Ingelheim Vetmedica Gmbh Subunidad s2 modificada de la proteina de espicula de coronavirus.
WO2020229257A1 (en) 2019-05-10 2020-11-19 Boehringer Ingelheim Vetmedica Gmbh Attenuated ibv with extended cell culture and tissue tropism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0639640T3 (da) * 1993-07-30 2001-01-02 Akzo Nobel Nv Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91
US6506385B1 (en) * 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith

Also Published As

Publication number Publication date
DK1259257T3 (da) 2010-06-14
CN1406135A (zh) 2003-03-26
ES2341841T3 (es) 2010-06-29
EP1259257B1 (en) 2010-04-07
EP1259257A2 (en) 2002-11-27
NO20024100D0 (no) 2002-08-28
AU2001237016A1 (en) 2001-09-12
YU65102A (sh) 2005-09-19
NO20024100L (no) 2002-10-09
CA2401145A1 (en) 2001-09-07
CY1110544T1 (el) 2015-04-29
NZ520761A (en) 2004-10-29
WO2001064244A2 (en) 2001-09-07
BR0108735A (pt) 2002-12-17
WO2001064244A3 (en) 2002-01-31
EP2198883A1 (en) 2010-06-23
MXPA02008254A (es) 2003-02-06
ATE463253T1 (de) 2010-04-15
PL365447A1 (en) 2005-01-10
PT1259257E (pt) 2010-06-01
AR027558A1 (es) 2003-04-02
DE60141743D1 (de) 2010-05-20
JP2003529565A (ja) 2003-10-07

Similar Documents

Publication Publication Date Title
GB2366693B (en) Software virus protection
AP2002002700A0 (en) Vaccine composition
HUP0302117A3 (en) Vaccine composition
GB0020953D0 (en) Vaccine
IL155282A0 (en) Vaccines
GB0020089D0 (en) Vaccine Composition
AU1591402A (en) Vaccine
GB0024200D0 (en) Component vaccine
GB0017720D0 (en) Modified virus
GB0014288D0 (en) Vaccine
IL151039A0 (en) In ovo protection against infectious bronchitis
GB0014845D0 (en) Vaccine
GB0027343D0 (en) Aircraft protection
GB0003082D0 (en) Vaccine
GB0027433D0 (en) Vaccine component
GB0004533D0 (en) Vaccines
GB0015722D0 (en) Vaccine
GB0006693D0 (en) Vaccine
PL365842A1 (en) Sentinel virus ii
GB0006770D0 (en) Vaccine composition
GB0015935D0 (en) Vaccine
GB0017011D0 (en) Easy protect
IL135013A0 (en) Protection against blows
GB0023747D0 (en) Secure e-mail
GB0103643D0 (en) Improvements in protecting filis